The earnings call reflected a mix of positive financial results exceeding expectations and strategic operational successes, tempered by challenges in professional services revenue, retention pressures, and migration-related headwinds.
Company Guidance
During the Health Catalyst Third Quarter 2025 Earnings Conference Call, the company provided key financial metrics and guidance. Total revenue for Q3 2025 was reported at $76.3 million, with an adjusted EBITDA of $12 million, surpassing their guidance. Technology segment revenue reached $52.1 million, marking a 7% year-over-year growth, while the adjusted gross margin increased by approximately 50 basis points to 53%. For the full year 2025, Health Catalyst reaffirmed its revenue guidance of $310 million and an adjusted EBITDA of $41 million. The company anticipates adding approximately 30 net new platform clients by the end of 2025, with an average booking size at the lower end of the $300,000 to $700,000 range. Looking into 2026, they expect revenue performance to slightly decline due to factors such as a dollar-based retention rate in the low 90s and Ignite migration challenges, but anticipate improved adjusted EBITDA through strategic focus and cost management.
Exceeded Financial Guidance in Q3 2025
Total revenue was $76.3 million and adjusted EBITDA was $12 million, both exceeding guidance.
Technology Revenue Growth
Technology segment revenue increased by 7% year-over-year to $52.1 million.
Operational Cost Savings
Temple University Health System and Entegris Health achieved significant cost savings utilizing Health Catalyst's solutions, with $7.5 million and $30 million saved respectively.
Adjusted Gross Margin Improvement
Total adjusted gross margin increased by approximately 50 basis points year-over-year to 53%.
Strong EBITDA Growth
Adjusted EBITDA in Q3 2025 was $12 million, up 64% compared to Q3 2024.
Health Catalyst (HCAT) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HCAT Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 10, 2025
$2.85
$2.69
-5.61%
Aug 07, 2025
$3.69
$2.83
-23.31%
May 07, 2025
$3.97
$4.18
+5.29%
Feb 26, 2025
$4.94
$4.39
-11.13%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Health Catalyst (HCAT) report earnings?
Health Catalyst (HCAT) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
What is Health Catalyst (HCAT) earnings time?
Health Catalyst (HCAT) earnings time is at Mar 03, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.